Loading…
Comparison of Survival Outcomes between Radical Antegrade Modular Pancreatosplenectomy and Conventional Distal Pancreatosplenectomy for Pancreatic Body and Tail Cancer: Korean Multicenter Propensity Score Match Analysis
(1) Background: The aim of this study was to compare the survival benefit of radical antegrade modular pancreatosplenectomy (RAMPS) with conventional distal pancreatosplenectomy (cDPS) in left-sided pancreatic cancer. (2) Methods: A retrospective propensity score matching (PSM) analysis was conducte...
Saved in:
Published in: | Cancers 2024-04, Vol.16 (8), p.1546 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c320t-611941813a082ba3c9ed51b324c007ddb9bd8fe1693eece2aef93af68eccae953 |
container_end_page | |
container_issue | 8 |
container_start_page | 1546 |
container_title | Cancers |
container_volume | 16 |
creator | Kwon, Jaewoo Lee, Huisong Kim, Hongbeom Kim, Sung Hyun Yang, Jae Do Lee, Woohyung Lee, Jun Suh Shin, Sang Hyun Kim, Hee Joon |
description | (1) Background: The aim of this study was to compare the survival benefit of radical antegrade modular pancreatosplenectomy (RAMPS) with conventional distal pancreatosplenectomy (cDPS) in left-sided pancreatic cancer. (2) Methods: A retrospective propensity score matching (PSM) analysis was conducted on 333 patients who underwent RAMPS or cDPS for left-sided pancreatic cancer at four tertiary cancer centers. The study assessed prognostic factors and compared survival and operative outcomes. (3) Results: After PSM, 99 patients were matched in each group. RAMPS resulted in a higher retrieved lymph node count than cDPS (15.0 vs. 10.0,
< 0.001). No significant differences were observed between the two groups in terms of R0 resection rate, blood loss, hospital stay, or morbidity. The 5-year overall survival rate was similar in both groups (cDPS vs. RAMPS, 44.4% vs. 45.2%,
= 0.853), and disease-free survival was also comparable. Multivariate analysis revealed that ASA score, preoperative CA19-9, histologic differentiation, R1 resection, adjuvant treatment, and lymphovascular invasion were significant prognostic factors for overall survival. Preoperative CA19-9, histologic differentiation, T-stage, adjuvant treatment, and lymphovascular invasion were independent significant prognostic factors for disease-free survival. (4) Conclusions: Although RAMPS resulted in a higher retrieved lymph node count, survival outcomes were not different between the two groups. RAMPS was a surgical option to achieve R0 resection rather than a standard procedure. |
doi_str_mv | 10.3390/cancers16081546 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3047951358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3046719334</sourcerecordid><originalsourceid>FETCH-LOGICAL-c320t-611941813a082ba3c9ed51b324c007ddb9bd8fe1693eece2aef93af68eccae953</originalsourceid><addsrcrecordid>eNptkUFv1DAQhSMEolXpmRuyxIXLUjtOnJhbCdBWdFVEyzma2BNw5djBdhbtb-XP4HYLrSp8GUvve08zekXxktG3nEt6pMApDJEJ2rK6Ek-K_ZI25UoIWT198N8rDmO8pvlxzhrRPC_2eCuaUpTtfvG789MMwUTviB_J5RI2ZgOWXCxJ-QkjGTD9QnTkK2ijsnDsEn4PoJGsvV4sBPIlrxEQko-zRYcq-WlLwGnSebdBl4x32ffBxJTHf-HR36cYRd57vQu4AmNJd3vlO_LZZ9mR9WIzk2Mxe4Kf0UWTtuRSZZmsIakfeUWw22jii-LZCDbi4d08KL59-njVna7OL07OuuPzleIlTSvBmKxYyzjQthyAK4m6ZgMvK0Vpo_UgB92OyITkiApLwFFyGEWLSgHKmh8Ub3a5c_A_F4ypn0xUaC049EvsOa0aWTNetxl9_Qi99kvI-95SomGS8ypTRztKBR9jwLGfg5kgbHtG-5vq-0fVZ8eru9xlmFD_4_8Wzf8Ao-axcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3046719334</pqid></control><display><type>article</type><title>Comparison of Survival Outcomes between Radical Antegrade Modular Pancreatosplenectomy and Conventional Distal Pancreatosplenectomy for Pancreatic Body and Tail Cancer: Korean Multicenter Propensity Score Match Analysis</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Kwon, Jaewoo ; Lee, Huisong ; Kim, Hongbeom ; Kim, Sung Hyun ; Yang, Jae Do ; Lee, Woohyung ; Lee, Jun Suh ; Shin, Sang Hyun ; Kim, Hee Joon</creator><creatorcontrib>Kwon, Jaewoo ; Lee, Huisong ; Kim, Hongbeom ; Kim, Sung Hyun ; Yang, Jae Do ; Lee, Woohyung ; Lee, Jun Suh ; Shin, Sang Hyun ; Kim, Hee Joon</creatorcontrib><description>(1) Background: The aim of this study was to compare the survival benefit of radical antegrade modular pancreatosplenectomy (RAMPS) with conventional distal pancreatosplenectomy (cDPS) in left-sided pancreatic cancer. (2) Methods: A retrospective propensity score matching (PSM) analysis was conducted on 333 patients who underwent RAMPS or cDPS for left-sided pancreatic cancer at four tertiary cancer centers. The study assessed prognostic factors and compared survival and operative outcomes. (3) Results: After PSM, 99 patients were matched in each group. RAMPS resulted in a higher retrieved lymph node count than cDPS (15.0 vs. 10.0,
< 0.001). No significant differences were observed between the two groups in terms of R0 resection rate, blood loss, hospital stay, or morbidity. The 5-year overall survival rate was similar in both groups (cDPS vs. RAMPS, 44.4% vs. 45.2%,
= 0.853), and disease-free survival was also comparable. Multivariate analysis revealed that ASA score, preoperative CA19-9, histologic differentiation, R1 resection, adjuvant treatment, and lymphovascular invasion were significant prognostic factors for overall survival. Preoperative CA19-9, histologic differentiation, T-stage, adjuvant treatment, and lymphovascular invasion were independent significant prognostic factors for disease-free survival. (4) Conclusions: Although RAMPS resulted in a higher retrieved lymph node count, survival outcomes were not different between the two groups. RAMPS was a surgical option to achieve R0 resection rather than a standard procedure.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers16081546</identifier><identifier>PMID: 38672628</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adjuvant therapy ; Antigens ; Dissection ; Fistula ; Hospitals ; Lymph nodes ; Lymphatic system ; Medical prognosis ; Metastasis ; Morbidity ; Mortality ; Multivariate analysis ; Pancreatic cancer ; Patients ; Survival</subject><ispartof>Cancers, 2024-04, Vol.16 (8), p.1546</ispartof><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c320t-611941813a082ba3c9ed51b324c007ddb9bd8fe1693eece2aef93af68eccae953</cites><orcidid>0000-0002-8636-5726 ; 0000-0001-7683-9687 ; 0000-0001-8922-4374 ; 0000-0001-9701-7666</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3046719334/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3046719334?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25751,27922,27923,37010,37011,44588,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38672628$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kwon, Jaewoo</creatorcontrib><creatorcontrib>Lee, Huisong</creatorcontrib><creatorcontrib>Kim, Hongbeom</creatorcontrib><creatorcontrib>Kim, Sung Hyun</creatorcontrib><creatorcontrib>Yang, Jae Do</creatorcontrib><creatorcontrib>Lee, Woohyung</creatorcontrib><creatorcontrib>Lee, Jun Suh</creatorcontrib><creatorcontrib>Shin, Sang Hyun</creatorcontrib><creatorcontrib>Kim, Hee Joon</creatorcontrib><title>Comparison of Survival Outcomes between Radical Antegrade Modular Pancreatosplenectomy and Conventional Distal Pancreatosplenectomy for Pancreatic Body and Tail Cancer: Korean Multicenter Propensity Score Match Analysis</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>(1) Background: The aim of this study was to compare the survival benefit of radical antegrade modular pancreatosplenectomy (RAMPS) with conventional distal pancreatosplenectomy (cDPS) in left-sided pancreatic cancer. (2) Methods: A retrospective propensity score matching (PSM) analysis was conducted on 333 patients who underwent RAMPS or cDPS for left-sided pancreatic cancer at four tertiary cancer centers. The study assessed prognostic factors and compared survival and operative outcomes. (3) Results: After PSM, 99 patients were matched in each group. RAMPS resulted in a higher retrieved lymph node count than cDPS (15.0 vs. 10.0,
< 0.001). No significant differences were observed between the two groups in terms of R0 resection rate, blood loss, hospital stay, or morbidity. The 5-year overall survival rate was similar in both groups (cDPS vs. RAMPS, 44.4% vs. 45.2%,
= 0.853), and disease-free survival was also comparable. Multivariate analysis revealed that ASA score, preoperative CA19-9, histologic differentiation, R1 resection, adjuvant treatment, and lymphovascular invasion were significant prognostic factors for overall survival. Preoperative CA19-9, histologic differentiation, T-stage, adjuvant treatment, and lymphovascular invasion were independent significant prognostic factors for disease-free survival. (4) Conclusions: Although RAMPS resulted in a higher retrieved lymph node count, survival outcomes were not different between the two groups. RAMPS was a surgical option to achieve R0 resection rather than a standard procedure.</description><subject>Adjuvant therapy</subject><subject>Antigens</subject><subject>Dissection</subject><subject>Fistula</subject><subject>Hospitals</subject><subject>Lymph nodes</subject><subject>Lymphatic system</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Multivariate analysis</subject><subject>Pancreatic cancer</subject><subject>Patients</subject><subject>Survival</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkUFv1DAQhSMEolXpmRuyxIXLUjtOnJhbCdBWdFVEyzma2BNw5djBdhbtb-XP4HYLrSp8GUvve08zekXxktG3nEt6pMApDJEJ2rK6Ek-K_ZI25UoIWT198N8rDmO8pvlxzhrRPC_2eCuaUpTtfvG789MMwUTviB_J5RI2ZgOWXCxJ-QkjGTD9QnTkK2ijsnDsEn4PoJGsvV4sBPIlrxEQko-zRYcq-WlLwGnSebdBl4x32ffBxJTHf-HR36cYRd57vQu4AmNJd3vlO_LZZ9mR9WIzk2Mxe4Kf0UWTtuRSZZmsIakfeUWw22jii-LZCDbi4d08KL59-njVna7OL07OuuPzleIlTSvBmKxYyzjQthyAK4m6ZgMvK0Vpo_UgB92OyITkiApLwFFyGEWLSgHKmh8Ub3a5c_A_F4ypn0xUaC049EvsOa0aWTNetxl9_Qi99kvI-95SomGS8ypTRztKBR9jwLGfg5kgbHtG-5vq-0fVZ8eru9xlmFD_4_8Wzf8Ao-axcw</recordid><startdate>20240418</startdate><enddate>20240418</enddate><creator>Kwon, Jaewoo</creator><creator>Lee, Huisong</creator><creator>Kim, Hongbeom</creator><creator>Kim, Sung Hyun</creator><creator>Yang, Jae Do</creator><creator>Lee, Woohyung</creator><creator>Lee, Jun Suh</creator><creator>Shin, Sang Hyun</creator><creator>Kim, Hee Joon</creator><general>MDPI AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8636-5726</orcidid><orcidid>https://orcid.org/0000-0001-7683-9687</orcidid><orcidid>https://orcid.org/0000-0001-8922-4374</orcidid><orcidid>https://orcid.org/0000-0001-9701-7666</orcidid></search><sort><creationdate>20240418</creationdate><title>Comparison of Survival Outcomes between Radical Antegrade Modular Pancreatosplenectomy and Conventional Distal Pancreatosplenectomy for Pancreatic Body and Tail Cancer: Korean Multicenter Propensity Score Match Analysis</title><author>Kwon, Jaewoo ; Lee, Huisong ; Kim, Hongbeom ; Kim, Sung Hyun ; Yang, Jae Do ; Lee, Woohyung ; Lee, Jun Suh ; Shin, Sang Hyun ; Kim, Hee Joon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c320t-611941813a082ba3c9ed51b324c007ddb9bd8fe1693eece2aef93af68eccae953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adjuvant therapy</topic><topic>Antigens</topic><topic>Dissection</topic><topic>Fistula</topic><topic>Hospitals</topic><topic>Lymph nodes</topic><topic>Lymphatic system</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Multivariate analysis</topic><topic>Pancreatic cancer</topic><topic>Patients</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kwon, Jaewoo</creatorcontrib><creatorcontrib>Lee, Huisong</creatorcontrib><creatorcontrib>Kim, Hongbeom</creatorcontrib><creatorcontrib>Kim, Sung Hyun</creatorcontrib><creatorcontrib>Yang, Jae Do</creatorcontrib><creatorcontrib>Lee, Woohyung</creatorcontrib><creatorcontrib>Lee, Jun Suh</creatorcontrib><creatorcontrib>Shin, Sang Hyun</creatorcontrib><creatorcontrib>Kim, Hee Joon</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kwon, Jaewoo</au><au>Lee, Huisong</au><au>Kim, Hongbeom</au><au>Kim, Sung Hyun</au><au>Yang, Jae Do</au><au>Lee, Woohyung</au><au>Lee, Jun Suh</au><au>Shin, Sang Hyun</au><au>Kim, Hee Joon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Survival Outcomes between Radical Antegrade Modular Pancreatosplenectomy and Conventional Distal Pancreatosplenectomy for Pancreatic Body and Tail Cancer: Korean Multicenter Propensity Score Match Analysis</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2024-04-18</date><risdate>2024</risdate><volume>16</volume><issue>8</issue><spage>1546</spage><pages>1546-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>(1) Background: The aim of this study was to compare the survival benefit of radical antegrade modular pancreatosplenectomy (RAMPS) with conventional distal pancreatosplenectomy (cDPS) in left-sided pancreatic cancer. (2) Methods: A retrospective propensity score matching (PSM) analysis was conducted on 333 patients who underwent RAMPS or cDPS for left-sided pancreatic cancer at four tertiary cancer centers. The study assessed prognostic factors and compared survival and operative outcomes. (3) Results: After PSM, 99 patients were matched in each group. RAMPS resulted in a higher retrieved lymph node count than cDPS (15.0 vs. 10.0,
< 0.001). No significant differences were observed between the two groups in terms of R0 resection rate, blood loss, hospital stay, or morbidity. The 5-year overall survival rate was similar in both groups (cDPS vs. RAMPS, 44.4% vs. 45.2%,
= 0.853), and disease-free survival was also comparable. Multivariate analysis revealed that ASA score, preoperative CA19-9, histologic differentiation, R1 resection, adjuvant treatment, and lymphovascular invasion were significant prognostic factors for overall survival. Preoperative CA19-9, histologic differentiation, T-stage, adjuvant treatment, and lymphovascular invasion were independent significant prognostic factors for disease-free survival. (4) Conclusions: Although RAMPS resulted in a higher retrieved lymph node count, survival outcomes were not different between the two groups. RAMPS was a surgical option to achieve R0 resection rather than a standard procedure.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38672628</pmid><doi>10.3390/cancers16081546</doi><orcidid>https://orcid.org/0000-0002-8636-5726</orcidid><orcidid>https://orcid.org/0000-0001-7683-9687</orcidid><orcidid>https://orcid.org/0000-0001-8922-4374</orcidid><orcidid>https://orcid.org/0000-0001-9701-7666</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6694 |
ispartof | Cancers, 2024-04, Vol.16 (8), p.1546 |
issn | 2072-6694 2072-6694 |
language | eng |
recordid | cdi_proquest_miscellaneous_3047951358 |
source | Publicly Available Content Database; PubMed Central |
subjects | Adjuvant therapy Antigens Dissection Fistula Hospitals Lymph nodes Lymphatic system Medical prognosis Metastasis Morbidity Mortality Multivariate analysis Pancreatic cancer Patients Survival |
title | Comparison of Survival Outcomes between Radical Antegrade Modular Pancreatosplenectomy and Conventional Distal Pancreatosplenectomy for Pancreatic Body and Tail Cancer: Korean Multicenter Propensity Score Match Analysis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A02%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Survival%20Outcomes%20between%20Radical%20Antegrade%20Modular%20Pancreatosplenectomy%20and%20Conventional%20Distal%20Pancreatosplenectomy%20for%20Pancreatic%20Body%20and%20Tail%20Cancer:%20Korean%20Multicenter%20Propensity%20Score%20Match%20Analysis&rft.jtitle=Cancers&rft.au=Kwon,%20Jaewoo&rft.date=2024-04-18&rft.volume=16&rft.issue=8&rft.spage=1546&rft.pages=1546-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers16081546&rft_dat=%3Cproquest_cross%3E3046719334%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c320t-611941813a082ba3c9ed51b324c007ddb9bd8fe1693eece2aef93af68eccae953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3046719334&rft_id=info:pmid/38672628&rfr_iscdi=true |